Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4270055 | The Journal of Sexual Medicine | 2013 | 14 Pages |
Abstract
These findings suggest that apelin-APJ signaling is a potential therapeutic target in the treatment of vasculogenic ED. Further studies are needed to develop a potent agonist for APJ and to determine the role of repeated dosing of apelin on longâterm recovery of erectile function. Kwon MâH, Tuvshintur B, Kim WJ, Jin HâR, Yin GN, Song KâM, Choi MJ, Kwon KâD, Batbold D, Ryu JâK, and Suh JâK. Expression of the apelin-APJ pathway and effects on erectile function in a mouse model of vasculogenic erectile dysfunction. J Sex Med 2013;10:2928-2941.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
MiâHye MS, Buyankhuu MS, Woo Jean PhD, HaiâRong MD, PhD, Guo Nan PhD, KangâMoon MS, Min Ji MS, KiâDong BS, Dulguun BS, JiâKan MD, PhD, JunâKyu MD, PhD,